Case study: daratumumab in a relapsed patient
Oncogenic mutational networks in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)
Discussion of the two biologies of DLBCL - the GCB and ABC subtype and potential targeted therapies
Why is supportive care important in myeloma?
RESONATE, RESONATE-2 and HELIOS: three major clinical trials in CLL research
Thomas J. Kipps